Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Omeprazole on Dalpiciclib PK in Healthy Subjects
NCT04989829Phase 1Completed
- Sponsor
- Hengrui
- Start
- Dec 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of dalpiciclib in solid tumor, sponsored by Hengrui. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve from time zero to last measurable concentration and 1 more. Started Dec 2021; status: completed.
02
Drugs
dalpiciclib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04989829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04989829.